Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The overarching goal is to incorporate patient-centered measures with clinical data to understand the impact of outcomes and events on patients, too assess associations of QOL and other factors to inform interventions, and overall management of late effects and survivorship of recipients of cellular therapies
shared new data from the Phase III CONVOKE study of their investigational prescription digital therapeutic (PDT) for #schizophrenia, CT-155, at the European College of Neuropsychopharmacology (ECNP) congress
Gave the best recommendations and was super knowledgeable with all the questions I had
If you are in a rapid weight-loss phase, the floor is not where you want to be
US$ 27.44
US$ 28.26
US$ 27.28
